Calcium Antagonists in the Post-Myocardial Infarction Setting

ISSN： 1170-229X

Source： Drugs & Aging, Vol.15, Iss.6, 1999-12, pp. : 461-470

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Underutilization of -Adrenoceptor Antagonists Post-Myocardial Infarction

By Gutierrez Michael E. Labovitz Arthur J.

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 1, 2005-01 ,pp. : 23-29

Adis International

Access to resources Recommend Favorite

The pharmacokinetics and pharmacodynamics of valsartan in the post-myocardial infarction population

By Benge Cassandra D Muldowney James A S

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1469-1482

Informa Healthcare

Access to resources Recommend Favorite

Fibrosis as a Therapeutic Target Post-Myocardial Infarction

Current Pharmaceutical Design, Vol. 11, Iss. 4, 2005-02 ,pp. : 477-487

Bentham Science Publishers

Access to resources Recommend Favorite

Regenerative Approaches to Post-Myocardial Infarction Heart Failure

Current Pharmaceutical Design, Vol. 20, Iss. 12, 2014-04 ,pp. : 1930-1940

Bentham Science Publishers

Access to resources Recommend Favorite

Tissue Engineering for Post-Myocardial Infarction Ventricular Remodeling

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 3, 2011-01 ,pp. : 263-270

Bentham Science Publishers

Access to resources Recommend Favorite